Most Recent Articles about EC
https://www.zacks.com/stock/news/2249839/bristol-myers-bmy-wins-ec-nod-for-reblozyl-label-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249839
Apr 03, 2024 - Bristol Myers (BMY) receives European Commission's approval for a label expansion of Reblozyl (luspatercept) for another indication.
zc:1401251990396007315
0
https://www.zacks.com/stock/news/2246882/ecopetrol-ec-wins-dispute-awarded-mcdermott-share-capital?cid=CS-ZC-FT-analyst_blog|company_news_-_energy_sector-2246882
Mar 27, 2024 - Ecopetrol's (EC) Reficar receives the 19.9% convertible preferred shares of McDermott International under a financial restructuring plan proposed by its subsidiary, CB&I N.V.
zc:2860547445961927423
0
https://seekingalpha.com/article/4675412-ecopetrol-s-ec-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Mar 01, 2024 - Ecopetrol S.A. (NYSE:NYSE:EC) Q4 2023 Earnings Call Transcript March 1, 2024 9:00 AM ETCompany ParticipantsRicardo Roa - CEOAlberto Consuegra - COODavid...
0
sa:-2820569996225277868
0